ENA Respiratory secures US$22.4m to advance nasal spray therapy
22nd October 2025 Uncategorised 0
Funding to support phase 2 trial of INNA-051 aimed at preventing viral respiratory infections

More: ENA Respiratory secures US.4m to advance nasal spray therapy
Source: News
